Clinical decision support
Guidelines & calculatorsPractice guidelines and risk calculators
Third-party guidelines and prediction tools relevant to IBD surgery, each independently verified against PubMed. These are external documents and tools, linked, not reproduced, and not evidence-gated by this site.
Read the access and validation labels. Very few published IBD prediction tools are simultaneously a live free calculator, externally validated, and validated for the decision you are about to make. Where a tool is formula-only, or was validated only in its derivation cohort, that is stated rather than hidden behind a link. 2 further item(s) found by this review are withheld pending clinician sign-off rather than published unverified.
Practice guidelines
- Clinical Practice Guideline for the Surgical Management of Ulcerative Colitis
- ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
- The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn's Disease
- ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment
- ACG Clinical Guideline Update: Ulcerative Colitis in Adults
- ACG Clinical Guideline: Management of Crohn's Disease in Adults
- AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders
- ECCO Topical Review on Pouch Disorders
- British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease
- British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025
- The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula
- The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Reduction of Venous Thromboembolic Disease in Colorectal Surgery
- ESPEN guideline on Clinical Nutrition in inflammatory bowel disease
Risk calculators and prediction tools
- ACS NSQIP Surgical Risk Calculator (v4.0.4) Note: It has been formally externally validated in IBD surgery and it FAILED. Lin et al. (J Crohns Colitis 2023;17(1):73-82; PMID 35973971) found c-statistics of 0.605 any complication, 0.623 serious complication, 0.590 reoperation, 0.621 readmission, 0.574 anastomotic leak, with systematic UNDERESTIMATION of risk. Discrimination is barely above chance in IBD. Do not quote its absolute percentages to an IBD patient; the authors call for recalibration or added variables. This is the only free web tool covering IBD operations, which is exactly why the failure needs to be stated on the page.
- Travis (Oxford) criteria, day 3 of acute severe ulcerative colitis Note: Derived 1996 from 48 patients. Its original 85% same-admission colectomy PPV is OBSOLETE. In the biologic era, observed in-hospital colectomy among Oxford-positive patients is roughly 20–36%. It remains a valid discriminator of steroid non-response (independent predictor, and meta-analytic OR ~4.4 for colectomy), so use it to trigger a rescue-therapy decision, never to quote a colectomy probability to a patient. Derivation PMID left blank. The original 1996 Gut record was not independently verified and was not guessed.
- ASUC 1-year colectomy score (Le Baut / Saint-Antoine IBD Network) Note: Genuinely validated in a separate 185-patient cohort at two other French centres, but there is NO web implementation, it must be scored by hand. Both cohorts are retrospective, French, and from 2002–2017, i.e. before JAK inhibitors and S1P modulators changed rescue therapy. The extreme strata rest on very small numbers (score 4 = 100% colectomy), so the upper end is imprecise; its real strength is as a negative predictor (NPV 87–92% for score 0).
- Postdischarge VTE risk calculator for IBD surgery (Schlick et al.) Note: DERIVATION ONLY, no external validation and no published web implementation. Built on ACS NSQIP colectomy/proctectomy targeted modules 2012–2018 (n=18,990) with a very rare outcome: 199 events (1.1%), so estimates are unstable in the tails. Do not use it as the sole justification for or against extended prophylaxis; pair it with the ASCRS 2023 VTE guideline, which is the graded recommendation.
- Postoperative Crohn's disease recurrence nomogram (biologic era) Note: Externally validated in two independent international cohorts, but AUC is only 0.72, adequate for group-level stratification, weak for individual prediction. No web implementation; nomogram lives in the paper. PMID was not retrievable at time of search (published online ~March 2026), cite by DOI and re-check before publishing. Note the paper's own headline result is that biologic prophylaxis reduced recurrence (OR 0.31) irrespective of risk factors, which argues against using the score to withhold prophylaxis from low-risk patients.